Company intelligence / Profile preview

Shanghai Runshi Pharmaceutical

Shanghai, Shanghai Shi/Shanghai Municipality, Chinaditchcarbon.com ↗
Ownership
Private
Development stage
Other
01

Overview

Shanghai Runshi Pharmaceutical has an active pipeline with at least five clinical-stage programs targeting oncology indications. Its most advanced assets are in Phase 3 trials for small cell lung cancer and metastatic esophageal squamous cell carcinoma. The company develops both small molecules and biologics including monoclonal antibodies and antibody-drug conjugates. It is a subsidiary/joint venture under CSPC Pharmaceutical Group.

Therapeutic areas
Oncology
Modalities
Small moleculeAntibody-drug conjugateMonoclonal antibody
Industry
Biotech
02

Partnerships

Parent company CSPC collaborates widely with academic institutions such as SIMM/Chinese Academy of Sciences; specific partnerships for this subsidiary are not detailed but likely benefit from group-level alliances.

Beyond the preview

Go deeper on Shanghai Runshi Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shanghai Runshi Pharmaceutical.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call